Stocks & ETFs Screener: 96 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
966B | 82.8% | 71.3% | 57.8% | 52.9 | 18.2% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
501B | 74.2% | 60.2% | 64.4% | 20.1 | 25.7% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
287B | 86.4% | 42.1% | 46.0% | 30.8 | 6.80% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
286B | 82.8% | 39.1% | 58.1% | 30.6 | 21.8% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
266B | 91.8% | 58.9% | 70.0% | 19.0 | 24.8% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
266B | 83.0% | 62.9% | 39.7% | 14.1 | -5.14% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
234B | 89.3% | 40.0% | -49.9% | 14.3 | -47.1% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
142B | 57.4% | 74.6% | -14.3% | 14.6 | -14.2% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
117B | 63.6% | 54.5% | 14.0% | 15.7 | -11.6% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.2% | 64.1% | -19.2% | 15.6 | -23.0% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
111B | 73.8% | 58.8% | -7.75% | 18.4 | -13.8% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.1B | 79.3% | 19.7% | 75.8% | 13.6 | 28.1% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.7B | 80.1% | 31.3% | 50.4% | 13.7 | 11.9% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
61.7B | 61.6% | 37.6% | -27.4% | 17.7 | -25.8% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
54.9B | 88.5% | 71.2% | -53.2% | 20.6 | -33.6% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.1B | 62.5% | 35.2% | 53.9% | 224 | 4.69% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
41.6B | 47.1% | 1.0% | 34.7% | - | 58.0% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
34.8B | 53.2% | 17.8% | 69.0% | 49.8 | 20.3% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.9B | 58.0% | 71.1% | 74.3% | 22.4 | 33.7% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
14.1B | 28.7% | 58.8% | 22.3% | - | -11.9% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.8B | 77.6% | 45.1% | -8.10% | 17.8 | -23.6% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
11.6B | 87.4% | 50.2% | 24.6% | 22.3 | -7.06% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.1B | 42.9% | - | 66.0% | 320 | 61.0% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.3B | 51.2% | - | 46.2% | - | 16.8% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.71B | 67.5% | - | 56.8% | 95.0 | 36.9% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.75B | 32.3% | - | 61.2% | - | 51.1% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
4.61B | 34.7% | - | 64.2% | - | 532% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
4.05B | 61.4% | - | 75.9% | - | 39.3% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.50B | 36.6% | - | 59.8% | - | 25.9% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.47B | 85.5% | 57.1% | 36.4% | 22.2 | -5.32% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
3.39B | 36.4% | - | 33.0% | - | 20.6% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.11B | 26.0% | - | 73.9% | - | 152% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.09B | 63.9% | 0.21% | -30.4% | 15.6 | -31.6% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.97B | 46.7% | - | 71.2% | - | 17.7% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.71B | 29.9% | - | 48.4% | - | 26.7% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.66B | 51.7% | 4.23% | 0.33% | 7.40 | -21.6% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.24B | 91.9% | - | 11.3% | 12.3 | -5.72% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.13B | 73.3% | 49.2% | 9.28% | 16.9 | -14.1% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.12B | 63.8% | - | 58.5% | - | 73.2% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
2.02B | 24.8% | - | 91.2% | - | 128% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.89B | 48.1% | 73.1% | -65.8% | - | -51.4% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.87B | 56.7% | 50.8% | -62.3% | 3.76 | -57.6% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.86B | 44.1% | - | 66.6% | - | 26.3% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.85B | 69.4% | - | 57.2% | 51.4 | 28.0% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.66B | 37.5% | - | 73.5% | - | 164% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.9% | 2.39% | 32.7% | 13.4 | -4.05% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.57B | 80.0% | - | 61.6% | 30.4 | 46.7% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.51B | 27.3% | - | 77.0% | - | 119% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.51B | 61.7% | 34.5% | 57.3% | 22.3 | 55.8% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.49B | 22.2% | - | -70.5% | - | -44.4% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.47B | 32.2% | - | 69.5% | - | 37.6% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.37B | 30.2% | - | 24.9% | - | 170% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.32B | 46.7% | - | 44.5% | - | 3.76% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.26B | 65.2% | - | 69.2% | - | 84.9% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.25B | 76.4% | - | -9.36% | 11.9 | -38.0% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.21B | 47.7% | - | -43.3% | - | -40.6% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.20B | 63.0% | - | 42.1% | - | 83.6% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.19B | 62.8% | - | 14.5% | 56.4 | 17.9% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
1.09B | 41.4% | - | 54.7% | - | 35.8% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.05B | 47.6% | - | 38.6% | 24.9 | 14.9% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
993M | 32.7% | - | -38.8% | - | -38.7% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
976M | 92.1% | - | 61.3% | 5.61 | 30.3% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
953M | 32.5% | - | 51.4% | - | 166% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
949M | 51.2% | - | 84.9% | 32.9 | 67.6% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
893M | 39.5% | - | 0.25% | - | -46.1% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
778M | 22.9% | - | 53.3% | - | 108% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
716M | 59.2% | - | 57.6% | - | 43.3% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
668M | 51.4% | 30.2% | 30.6% | 1.03 | 947% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
647M | 33.8% | - | 61.9% | - | 250% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
621M | 43.9% | - | 57.4% | - | 270% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
505M | 46.6% | - | 65.5% | 1.03 | 107% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
483M | 16.2% | - | -50.7% | - | -63.4% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
463M | 30.5% | - | -10.5% | - | -27.8% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
458M | 50.9% | - | -42.6% | - | -16.3% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
449M | 79.6% | 88.5% | 17.1% | 6.09 | -1.49% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 28.9% | - | -47.9% | - | -46.6% |
| ETON Eton |
Pharmaceuticals
Growth Hormone Deficiency, enal |
444M | 56.3% | - | 35.7% | - | 8.78% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.3% | - | 83.4% | - | 728% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
329M | 32.8% | - | -0.90% | - | 2.90% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
308M | 25.5% | - | -10.1% | - | -16.7% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
302M | 49.5% | - | -32.7% | - | -86.5% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
283M | 30.4% | - | 8.51% | - | -7.69% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
259M | 66.9% | - | -37.5% | - | -9.96% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
258M | 21.4% | - | 12.5% | - | -3.98% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
241M | 20.1% | - | 19.2% | - | -11.6% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.9% | 1.0% | -63.1% | - | -78.7% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
166M | 24.4% | - | -5.25% | - | -22.1% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 33.9% | 0.17% | -45.0% | - | -23.5% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
139M | 39.9% | - | 28.2% | - | 51.9% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
137M | 45.7% | - | 0.28% | - | 35.9% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
133M | 26.1% | - | 13.4% | - | -1.82% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
106M | 29.9% | - | 29.5% | - | -10.2% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
101M | 67.5% | - | -37.6% | - | -19.4% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
13.4M | 39.1% | - | -75.7% | - | -99.2% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
6.68M | 25.4% | - | -68.3% | - | -92.0% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -30.3% | 1.45 | -52.5% |